Doctor explains mysterious UK virus that 'goes beyond cold or flu'

It can cause an infection that lasts for weeks ...
Scientific Research Publishing

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa ()

Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Arcutis Announces Positive Topline Results for INTEGUMENT-INFANT Phase 2 Trial of ZORYVE® (roflumilast) Cream 0.05% in Infants with Mild to Moderate Atopic Dermatitis

Eczema Area and Severity Index (EASI-75) with ZORYVE cream 0.05% at Week 4Investigational ZORYVE cream 0.05% was well tolerated and demonstrated a safety profile consistent with previous studies, with ...

Intellia Therapeutics: 2 Major Catalysts Will Determine Stock's Trajectory In 2026

NTLA stock faces binary risk: success could unlock multi-billion dollar markets, while setbacks may erase hundreds of ...
Medscape

New Treatments for Primary Biliary Cholangitis Remedy Poor Response to First-Line Drug

As the management landscape of primary biliary cholangitis (PBC) changes, new second-line options offer effective ...